Advanced Biomed Inc.
ADVB
$5.10
$0.357.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 64.67% | -- | -45.67% | 13.32% | -31.03% |
| Total Depreciation and Amortization | -58.67% | -- | -53.03% | -58.15% | -72.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.00% | -- | -- | -- | -- |
| Change in Net Operating Assets | 105.63% | -- | -303.07% | -604.90% | -4,513.10% |
| Cash from Operations | 92.97% | -- | -1,954.88% | -224.51% | -219.94% |
| Capital Expenditure | 40.91% | -- | 91.00% | 62.29% | -108.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 40.91% | -- | 91.00% | 62.29% | -108.24% |
| Total Debt Issued | -99.11% | -- | 12.07% | -55.81% | -51.34% |
| Total Debt Repaid | 1,527.27% | -- | -- | -- | -- |
| Issuance of Common Stock | -95.57% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -6,460.19% | 13.99% |
| Cash from Financing | -95.45% | -- | 14.01% | -336.63% | 949.27% |
| Foreign Exchange rate Adjustments | -173.55% | -- | 72.78% | -67.02% | -89.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.08% | -- | -734.36% | -3,993.72% | 2,338.18% |